Branched Stent Grafts Market Share, Size & Growth Report [2031]

Branched Stent Grafts Market Share, Size & Growth Report [2031]

Segments - Branched Stent Grafts Market by Types (Iliac Stent and Others), Applications (FEVAR, Chimney, and Others), and Regions (North America, Europe, Asia Pacific, Latin America, and Middle East & Africa) - Global Industry Analysis, Growth, Share, Size, Trends, and Forecast 2023 – 2031

https://growthmarketreports.com/raksha
Author : Raksha Sharma
https://growthmarketreports.com/Vaibhav
Fact-checked by : V. Chandola
https://growthmarketreports.com/Vishal
Editor : Vishal Golekar

Upcoming | Report ID :HC-4211 | 4.1 Rating | 62 Reviews | 198 Pages | Format : PDF Excel PPT

Report Description


Branched Stent Grafts Market Outlook 2031

The global branched stent grafts market size was valued at USD 303.09 Million in 2022 and is anticipated to reach USD 600.85 Million by 2031, expanding at a CAGR of 7.9% during the forecast period, 2023-2031. The global branched stent grafts market's products are used in a variety of EVAR [endovascular aneurysm repair] operations.

EVAR for significant aortic diseases such as aneurysms, traumatic ruptures, and dissections has acquired universal surgeon and patient acceptance owing to lower rates of morbidity and mortality. Also, slow growth and poor net sales were seen by companies in the vascular stents market.

Branched Stent Grafts Market Outlook

Elective procedures were a low priority when hospitals shifted resources to ICUs, and the majority of them were postponed, affecting product demand. Furthermore, a quick change in the practice of vascular surgery had a significant impact on intensive and anesthetic care.

Since its inception in the early 1990s, EVAR has been proven to be a viable therapy option for abdominal aortic aneurysm [AAA]. The global population of people aged 60 and up, who are more likely to develop AAA, is growing, making it a high-impact key driver for market expansion over the forecast period.

  • Rising frequency of endovascular aneurysm repair [EVAR] procedures, improvements in patient care quality, and advancements in medical technology are few of the primary reasons driving the global branching stent grafts market.
  • The global branching stent grafts market is driven by rising geriatric population and high frequency of AAA [abdominal aortic aneurysm].
  • Introduction of the new coronavirus and following pandemic has resulted in a drop in sales, slower growth rate, and the postponement of elective surgeries which is estimated to hamper the market.
  • the global branching stent grafts market is predicted to rise significantly due to the rising demand for minimally invasive surgical treatments.

Scope of Branched Stent Grafts Market Report

The report on the global branched stent grafts market includes an assessment of the market, size, share, trends, segments, and regional markets. The study includes an overview as well as dynamics.

Attributes

Details

Report Title

Branched Stent Grafts Market – Global Industry Analysis, Growth, Share, Size, Trends, and Forecast

Base Year

2022

Historic Data

2016-2021

Forecast Period

2023-2031

Segmentation

Types (Iliac Stent and Others), Applications (FEVAR, Chimney, and Others)

Regional Scope

North America, Europe, Asia Pacific, Latin America, and Middle East & Africa

Report Coverage

Company Share, Market Analysis and Size, Competitive Landscape, Growth Factors, and Trends, and Revenue Forecast

Key Players covered in the Report

Abbott, Alvimedica, Biotronik, Boston Scientific Corp, Cardinal Health (Cordis), Cook Medical, Endocr GmbH, Eucatech AG, Medtronic, Merit Medical Systems.

Branched Stent Grafts Market Segment Insights

Types Segment Analysis

Based on types, the global branched stent grafts market is bifurcated into iliac stent and others. The iliac stents segment accounted for a considerable market share in 2021 and is expected to grow at a significant CAGR during the forecast period. Increasing incidence of cardiovascular diseases [CVDs] over the world are expected to drive the market.

Rapid technical improvements and widespread acceptance of stenting operations are expected to enhance the segment's growth during the forecasted period. The other segment is expected to hold a substantial market share during forecast period.

The others segment includes gastric, renal, femoral, celiac, fenestrated/branched, and super mesenteric stent graft systems. Growth of the market is attributed to increasing geriatric population with rising incidence of digestive problems.

Branched Stent Grafts Market Types

Applications Segment Analysis

Based on applications, the global branched stent grafts market is segmented into EVAR. The EVAR segment is further sub-segmented into fenestrated endovascular aortic aneurysm repair [FEVAR], chimney, and others. The others segment held a significant market share in 2021.

Recent advancements in branched stent grafts have made it easier to treat a variety of aortic aneurysms, including those involving the visceral arteries. Furthermore, new generation iliac bifurcated devices have good intraoperative and long-term results, which helps the market expand.

The chimney segment is expected to grow at a substantial CAGR during the projected period. Endovascular aortic repair operations are becoming increasingly popular among patients around the world. In the United States, endovascular stent grafts are the preferred therapy for around 80% of aortic aneurysm cases. This is projected to fuel the market.

Branched Stent Grafts Market Applications

Regional Analysis

In terms of regions, the global branched stent grafts market is classified as North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. North America held a significant revenue share in 2021. The presence of well-developed healthcare infrastructure, significant actors, and reimbursement coverage in the region propel the market.

Furthermore, due to the huge presence of key participants, the regional market is quite competitive. On the other hand, Asia Pacific is anticipated to dominate the market during forecast period. The growth of market is attributed to growing healthcare spending and rapidly expanding medical tourism industry. The presence of high-quality healthcare infrastructure, convenience, and cheap treatment alternatives is likely to drive the regional market.

Branched Stent Grafts Market Region

Segments

Types

  • Iliac Stent
  • Others

Applications

  • FEVAR
  • Chimney
  • Others

Regions

  • North America
  • Europe
  • Latin America
  • Asia Pacific
  • Middle East & Africa

Key Players

  • Abbott
  • Alvimedica
  • Biotronik
  • Boston Scientific Corp
  • Cardinal Health (Cordis)
  • Cook Medical
  • Endocr GmbH
  • Eucatech AG
  • Medtronic
  • Merit Medical Systems

Competitive Landscape

Key players in the global branched stent-grafts market include Abbott, Alvimedica, Biotronik, Boston Scientific Corp, Cardinal Health (Cordis), Cook Medical, Endocr GmbH, Eucatech AG, Medtronic, Merit Medical Systems.

Some of these players are using several market strategies such as acquisitions, merger, collaborations, partnerships, capacity expansion, and product launches to enhance their market shares and to generate revenue and raise their production line of the business in the coming years.

Branched Stent Grafts Market Key Players

Table Of Content

1. Executive Summary
2. Assumptions and Acronyms Used
3. Research Methodology
4. Branched Stent Grafts Market Overview
  4.1. Introduction
     4.1.1. Market Taxonomy
     4.1.2. Market Definition
  4.2. Macro-Economic Factors
     4.2.1. Industry Outlook
  4.3. Branched Stent Grafts Market Dynamics
     4.3.1. Market Drivers
     4.3.2. Market Restraints
     4.3.3. Opportunity
     4.3.4. Market Trends
  4.4. Branched Stent Grafts Market - Supply Chain
  4.5. Global Branched Stent Grafts Market Forecast
     4.5.1. Branched Stent Grafts Market Size (US$ Mn) and Y-o-Y Growth
     4.5.2. Branched Stent Grafts Market Size (000’ Units) and Y-o-Y Growth
     4.5.3. Branched Stent Grafts Market Absolute $ Opportunity
5. Global Branched Stent Grafts Market Analysis and Forecast by Types
  5.1. Market Trends
  5.2. Introduction
     5.2.1. Basis Point Share (BPS) Analysis by Types
     5.2.2. Y-o-Y Growth Projections by Types
  5.3. Branched Stent Grafts Market Size and Volume Forecast by Types
     5.3.1. Iliac Stent
     5.3.2. Others
  5.4. Absolute $ Opportunity Assessment by Types
  5.5. Market Attractiveness/Growth Potential Analysis by Types
6. Global Branched Stent Grafts Market Analysis and Forecast by Region
  6.1. Market Trends
  6.2. Introduction
     6.2.1. Basis Point Share (BPS) Analysis by Region
     6.2.2. Y-o-Y Growth Projections by Region
  6.3. Branched Stent Grafts Market Size and Volume Forecast by Region
     6.3.1. North America
     6.3.2. Latin America
     6.3.3. Europe
     6.3.4. Asia Pacific
     6.3.5. Middle East and Africa (MEA)
  6.4. Absolute $ Opportunity Assessment by Region
  6.5. Market Attractiveness/Growth Potential Analysis by Region
  6.6. Global Branched Stent Grafts Demand Share Forecast, 2019-2026
7. North America Branched Stent Grafts Market Analysis and Forecast
  7.1. Introduction
     7.1.1. Basis Point Share (BPS) Analysis by Country
     7.1.2. Y-o-Y Growth Projections by Country
  7.2. North America Branched Stent Grafts Market Size and Volume Forecast by Country
     7.2.1. U.S.
     7.2.2. Canada
  7.3. Absolute $ Opportunity Assessment by Country
  7.4. North America Branched Stent Grafts Market Size and Volume Forecast by Types
     7.4.1. Iliac Stent
     7.4.2. Others
  7.5. Basis Point Share (BPS) Analysis by Types
  7.6. Y-o-Y Growth Projections by Types
  7.7. Market Attractiveness/Growth Potential Analysis
     7.7.1. By Country
     7.7.2. By Product Type
     7.7.3. By Application
  7.8. North America Branched Stent Grafts Demand Share Forecast, 2019-2026
8. Latin America Branched Stent Grafts Market Analysis and Forecast
  8.1. Introduction
     8.1.1. Basis Point Share (BPS) Analysis by Country
     8.1.2. Y-o-Y Growth Projections by Country
     8.1.3. Latin America Average Pricing Analysis
  8.2. Latin America Branched Stent Grafts Market Size and Volume Forecast by Country
      8.2.1. Brazil
      8.2.2. Mexico
      8.2.3. Rest of Latin America
   8.3. Absolute $ Opportunity Assessment by Country
  8.4. Latin America Branched Stent Grafts Market Size and Volume Forecast by Types
     8.4.1. Iliac Stent
     8.4.2. Others
  8.5. Basis Point Share (BPS) Analysis by Types
  8.6. Y-o-Y Growth Projections by Types
  8.7. Market Attractiveness/Growth Potential Analysis
     8.7.1. By Country
     8.7.2. By Product Type
     8.7.3. By Application
  8.8. Latin America Branched Stent Grafts Demand Share Forecast, 2019-2026
9. Europe Branched Stent Grafts Market Analysis and Forecast
  9.1. Introduction
     9.1.1. Basis Point Share (BPS) Analysis by Country
     9.1.2. Y-o-Y Growth Projections by Country
     9.1.3. Europe Average Pricing Analysis
  9.2. Europe Branched Stent Grafts Market Size and Volume Forecast by Country
     9.2.1. Germany
     9.2.2. France
     9.2.3. Italy
     9.2.4. U.K.
     9.2.5. Spain
     9.2.6. Russia
     9.2.7. Rest of Europe
  9.3. Absolute $ Opportunity Assessment by Country
  9.4. Europe Branched Stent Grafts Market Size and Volume Forecast by Types
     9.4.1. Iliac Stent
     9.4.2. Others
  9.5. Basis Point Share (BPS) Analysis by Types
  9.6. Y-o-Y Growth Projections by Types
  9.7. Market Attractiveness/Growth Potential Analysis
     9.7.1. By Country
     9.7.2. By Product Type
     9.7.3. By Application
  9.8. Europe Branched Stent Grafts Demand Share Forecast, 2019-2026
10. Asia Pacific Branched Stent Grafts Market Analysis and Forecast
  10.1. Introduction
     10.1.1. Basis Point Share (BPS) Analysis by Country
     10.1.2. Y-o-Y Growth Projections by Country
     10.1.3. Asia Pacific Average Pricing Analysis
  10.2. Asia Pacific Branched Stent Grafts Market Size and Volume Forecast by Country
     10.2.1. China
     10.2.2. Japan
     10.2.3. South Korea
     10.2.4. India
     10.2.5. Australia
     10.2.6. Rest of Asia Pacific (APAC)
  10.3. Absolute $ Opportunity Assessment by Country
  10.4. Asia Pacific Branched Stent Grafts Market Size and Volume Forecast by Types
     10.4.1. Iliac Stent
     10.4.2. Others
  10.5. Basis Point Share (BPS) Analysis by Types
  10.6. Y-o-Y Growth Projections by Types
  10.7. Market Attractiveness/Growth Potential Analysis
     10.7.1. By Country
     10.7.2. By Product Type
     10.7.3. By Application
  10.8. Asia Pacific Branched Stent Grafts Demand Share Forecast, 2019-2026
11. Middle East & Africa Branched Stent Grafts Market Analysis and Forecast
  11.1. Introduction
     11.1.1. Basis Point Share (BPS) Analysis by Country
     11.1.2. Y-o-Y Growth Projections by Country
     11.1.3. Middle East & Africa Average Pricing Analysis
  11.2. Middle East & Africa Branched Stent Grafts Market Size and Volume Forecast by Country
     11.2.1. Saudi Arabia
     11.2.2. South Africa
     11.2.3. UAE
     11.2.4. Rest of Middle East & Africa (MEA)
  11.3. Absolute $ Opportunity Assessment by Country
  11.4. Middle East & Africa Branched Stent Grafts Market Size and Volume Forecast by Types
     11.4.1. Iliac Stent
     11.4.2. Others
  11.5. Basis Point Share (BPS) Analysis by Types
  11.6. Y-o-Y Growth Projections by Types
  11.7. Market Attractiveness/Growth Potential Analysis
     11.7.1. By Country
     11.7.2. By Product Type
     11.7.3. By Application
  11.8. Middle East & Africa Branched Stent Grafts Demand Share Forecast, 2019-2026
12. Competition Landscape
  12.1. Global Branched Stent Grafts Market: Market Share Analysis
  12.2. Branched Stent Grafts Distributors and Customers
  12.3. Branched Stent Grafts Market: Competitive Dashboard
  12.4. Company Profiles (Details: Overview, Financials, Developments, Strategy)
     12.4.1. Abbott
     12.4.2. Alvimedica
     12.4.3. Biotronik
     12.4.4. Boston Scientific Corp
     12.4.5. Cardinal Health (Cordis)
     12.4.6. Cook Medical
     12.4.7. Endocr GmbH
     12.4.8. Eucatech AG&

Methodology

Our Clients

General Electric
sinopec
Honda Motor Co. Ltd.
Microsoft
Pfizer
Nestle SA
Dassault Aviation
General Mills